Investor's Business Daily on MSN
IBD stock of the day Penumbra lays the groundwork for 2026 acceleration
Penumbra is Friday's IBD Stock Of The Day following a strong third-quarter report and a "landmark" study vs. blood thinners.
Genetic and immunopathogenic mechanisms that overlap could explain the connection between psoriasis and IBD. A new study found that gastrointestinal signs and symptoms were more prevalent in psoriasis ...
The study of over 8000 patients with myeloproliferative neoplasms (MPNs) also found that these patients were 40% more likely to have a prior diagnosis of inflammatory bowel disease (IBD). A large ...
Meta: \{"__typename":"TimeAuthorPageMetadata","title":"Markham Heid \| TIME","description":"Read the latest stories by ...
Antibiotic pill in hand Adam S. Faye, MD, discusses how antibiotics increase the risk for IBD among older adults and the clinical implications of this finding. Inflammatory bowel disease (IBD) is a ...
Please provide your email address to receive an email when new articles are posted on . Among young patients with inflammatory bowel disease, most whom were positive for SARS-CoV-2, had a ...
Even if patients attain some form of remission, approximately 50% can still experience functional-type symptoms consistent with irritable bowel syndrome (IBS). 1,2 Frequently reported IBS symptoms ...
CHICAGO--(BUSINESS WIRE)--ADM (NYSE: ADM) has been named to the Investor’s Business Daily (IBD) 2022 Best ESG Companies List. The list recognizes companies with superior Environmental, Social and ...
The risk of IBD, lung cancer, and diabetes could be heightened by ultra-processed food consumption, according to increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results